CALIFORNIA NEUROAIDS TISSUE NETWORK (CNTN)

加州神经艾滋病组织网络 (CNTN)

• 批准号: 8174523
• 负责人: ERIC S DAAR
• 金额: $ 11.14万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8174523
• 关键词: AIDS neuropathy; Acquired Immunodeficiency Syndrome; Autopsy; California; Computer Retrieval of Information on Scientific Projects Database; Enrollment; Funding; Grant; Institution; Life Expectancy; Medical center; Neurologic; Patients; Protocols documentation; Recruitment Activity; Research; Research Personnel; Resources; Source; Specimen; Tissues; United States National Institutes of Health; cohort; design; follow-up

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an amended protocol to continue study for 5 more years. The California NeuroAIDS Tissue Network (CNTN) is a consortium of three Californian Medical Centers (UC San Diego, UC Irvine, and Harbor-UCLA) which proposes to collect neurologic specimens from AIDS patients. Harbor-UCLA component of CNTN is designed to identify, recruit, enroll, and assess a cohort of approximately 85 patients with life expectancies of less than one year of whom about 6 will be autopsied each year. The majority of these patients have been enrolled during the past 8 years. Patients will be replaced as they die or are lost to follow up to mantain a cohort of 70 patients.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项修订方案，可继续研究5年以上。加州神经艾滋病组织网络（CNTN）是一个由三个加州医学中心（加州大学圣地亚哥分校、加州大学欧文分校和加州大学洛杉矶分校哈博分校）组成的联盟，旨在收集艾滋病患者的神经标本。CNTN的Harbor-UCLA部分旨在识别、招募、登记和评估约85名预期寿命不到一年的患者，其中每年约有6名患者进行尸检。这些患者中的大多数是在过去8年中入组的。当患者死亡或失访时，将替换患者，以维持70例患者的队列。